See inside every stock. Pro
S&P 5007,757▲ 0.58%Nasdaq26,703▲ 1.05%Dow Jones52,856▲ 0.69%Nasdaq 10029,823▲ 1.13%VIX16.68▼ 3.64%US Dollar101.69▼ 0.01%Gold spot4,114▼ 0.44%WTI99.24▲ 2.15%
← GFSA3 page
XStocksXray
Market X-Ray report · 16 October 2026

Gafisa S.A (GFSA3)

Sao Paulo Exchange · Brazil · prices in BRL · close of 16 Oct 2026

Key indicators

Last closeBRL 0.350
52-week range0.200 – 7.530
Return, 1 month / 3 months+45.8% / −14.6%
Return, 1 year / 3 years−94.9% / −99.5%
TrendBelow its 200-day average
RSI (14)55
Volatility (1 year)100.1%
Worst drawdown (1 year)-97.2%
Average daily value traded1.90M BRL
Dividend yield–

Market X-Ray price-based

17/ 100 · High confidence · ahead of 5% of stocks on this exchange
Trend1
Momentum5
Stability (higher is calmer)5
Liquidity84
Income–

Five-year price chart navy: price · brown: 200-day average

-31.161152624085542021-102023-012024-042025-072026-10

About the company

Gafisa is a Brazilian homebuilder and real estate developer based in São Paulo. The company develops and builds residential properties, including apartment towers and gated communities, aimed at middle-income and higher-income buyers in Brazilian cities. Its activities span land acquisition, project development, construction and the sale of homes to individual purchasers, and it has also worked through partnerships and subsidiaries in the housing sector.

The shares are listed on the Sao Paulo Exchange in Brazil under the code GFSA3, and the price on this page is in Brazilian reais (BRL). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Gafisa S.A (GFSA3) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 0.350 on 16 October 2026.

Its price-based Market X-Ray is 17 out of 100 (a weak price profile), ranking 1,385 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 94.9% and over the last three months it fell 14.6%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Gafisa S.A (GFSA3)

The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange

Lens and metricValueScoreReading
Trend1 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-77.2%
From 52-week high-95.2%
Momentum5 · WeakLagging most stocks on this exchange.
3-month return-14.6%
6-month return-78.0%
12-month return, skipping the last month-96.5%
Stability (higher is calmer)5 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)100.1%
Worst drawdown, 1 year (smaller is calmer)-97.2%
Liquidity84 · StrongTrades actively.
Average daily value traded1.90M BRL
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Liquidity: Trades actively.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.
  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week−22.2%
1 month+45.8%
3 months−14.6%
6 months−78.0%
1 year−94.9%
3 years−99.5%
5 years–

Signals

50-day / 200-day average0.260 / 1.534
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.053

Technical summary

DailyNeutral5 bullish · 4 neutral · 7 bearish
WeeklyStrongly bearish2 bullish · 1 neutral · 9 bearish
MonthlyStrongly bearish0 bullish · 1 neutral · 7 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 22 Oct 2026